Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now São Paulo - Delayed Quote • BRL Abbott Laboratories (ABTT34.SA) Follow Compare 60.36 -1.04 (-1.69%) At close: April 10 at 4:39:22 PM GMT-3 All News Press Releases SEC Filings Abbott (ABT) Stock Moves -2%: What You Should Know Abbott (ABT) closed at $124.50 in the latest trading session, marking a -2% move from the prior day. Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device Dexcom stock surged Thursday after the Food and Drug Administration cleared its newest diabetes device for an extended 15-day period. Abbott's Q1 Earnings Coming Up, Medical Devices Arm in Focus ABT's Structural Heart, Rhythm Management and Neuromodulation businesses are likely to have driven its first-quarter 2025 performance. Here's Why You Should Add Cencora Stock to Your Portfolio Now COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. Astronics and Boston Beer have been highlighted as Zacks Bull and Bear of the Day Astronics and Boston Beer have been highlighted as Zacks Bull and Bear of the Day. Will Trump Tariffs Make or Break Healthcare Space? 3 Stocks to Rely On Investors looking to maintain exposure to healthcare can invest in large-cap U.S.-based companies like UHS, BMRN and ABT. Abbott (ABT) Earnings Expected to Grow: Should You Buy? Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store. TriSalus Life Sciences, Inc. (TLSI) Soars 6.6%: Is Further Upside Left in the Stock? TriSalus Life Sciences, Inc. (TLSI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. Abbott Laboratories' (NYSE:ABT) institutional investors lost 5.9% over the past week but have profited from longer-term gains Key Insights Institutions' substantial holdings in Abbott Laboratories implies that they have significant influence... ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps ICU Medical aims to enable healthcare systems to customize infusion setups, optimizing device footprint without compromising performance or safety. The Zacks Analyst Blog Highlights Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare are included in this Analyst Blog. Is Abbott Laboratories (ABT) the Most Profitable Dividend Stock to Buy Now? We recently published a list of the 8 Most Profitable Dividend Stocks to Buy Now. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other profitable dividend stocks. When it comes to profits, dividend investing is the first thing that springs to mind. Dividends represent a portion of […] 5 Defensive Stocks to Buy for a Safe Portfolio Amid Tariff-Led Mayhem Five defensive stocks to buy at this soaring volatility are TAP, CNP, WEC, BSX, HCA. Abbott Laboratories (ABT): One of the Best Dividend Kings to Buy for Safe Dividend Growth We recently published a list of the 12 Best Dividend Kings to Buy For Safe Dividend Growth. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best dividend kings. The importance of dividend stocks cannot be denied, even in today’s market environment, which is dominated by […] Will Weakness in Abbott Laboratories' (NYSE:ABT) Stock Prove Temporary Given Strong Fundamentals? It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has... The Dow Needs A Refresh. These New Members Could Make It Sing. The Dow Jones Industrial Average has lagged behind its flashier cousin, the S&P 500 index, in recent years, James Glassman writes in a guest commentary. Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock? Reasons to Add ABT Stock to Your Portfolio Right Now Investors feel optimistic about Abbott's robust strength in the EPD, Diabetes and Nutrition businesses. However, unfavorable forex impacts are concerning. Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season. Performance Overview Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return ABTT34.SA S&P 500 (^GSPC) YTD +4.25% -10.43% 1-Year +30.22% +2.08% 3-Year +30.75% +17.37%